// App-Quantinova.ai

P127 : Baricitinib Efficacy in Moderate Rheumatoid Arthritis - A Post-hoc Analysis from two Phase III Trials

Researchers

Presenter

  • Bruce W Kirkham

Principal Investigators

  • Elena Nikiphorou

  • Christopher J Edwards

  • Mohamed Sheesh

  • Ewa Haladyj

  • Jens Gerwien

  • Liliana Zaremba-Pechmann

  • Peter C Taylor

Medical Centers

  • Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom

  • Guy's And St Thomas NHS Foundation Trust, London, United Kingdom

  • NIHR Clinical research Facility, University Hospital Southampton, Southampton, UNITED KINGDOM

  • Centre for Rheumatic Diseases and Rheumatology Department, King’s College London, London, United Kingdom

Locations

  • United Kingdom

  • Germany

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Methotrexate

  • Baricitinib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved